Skip to content

Post-marketing international multicenter, prospective observational study of GaiaBone® Bioabsorbable Bone Graft for the treatment of cavitary bone defects

Post-marketing international multicenter, prospective observational study of GaiaBone® Bioabsorbable Bone Graft for the treatment of cavitary bone defects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108190
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-09-25
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lacunar Bone Defect

Interventions

GAIABONE Repair Material Group:None

Sponsors

Shanghai JiaoTong university Affiliated Sixth People‘s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–80 years, male or female; 2. Patients with lacunar bone defects caused by various reasons who require bone grafting; 3. Patients who, based on their own ,plan to use the moldable absorbable bone repair material produced by Lixin (Shenzhen) Medical Devices Co., Ltd. for bone defect repair; 4. Patients who voluntarily participate in the study, sign the informed consent form, and agree to attend clinical follow-ups; 5. It is recommended that each participating center be designated as a fixed follow-up site for its enrolled patients without changes to avoid patient mobility. Eligibility for enrollment requires meeting all the above five criteria simultaneously.

Exclusion criteria

Exclusion criteria: 1. Subjects expected to have poor compliance. 2. Patients participating in other clinical studies simultaneously. 3.Patients expected to be unable to attend follow-ups on time. 4. Subjects deemed unsuitable for this clinical study by the investigator for other reasons. If any of the above criteria are met, the subject will be excluded from enrollment.

Design outcomes

Primary

MeasureTime frame
Bone Graft Fusion Rate at 24 Weeks Postoperatively;

Secondary

MeasureTime frame
Bone Defect Healing Rate at Fixed Postoperative Observation Time Points;Lane-Sandhu Imaging Score;Subject Quality of Life Assessment;

Countries

China

Contacts

Public ContactYang Qingcheng

Shanghai JiaoTong university Affiliated Sixth People‘s Hospital

tjyqc@163.com+86 189 3017 7328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026